|
46 Companies |
|
12 Products |
|
12 Products |
|
17 Mechanisms of Action |
|
756 Trials |
|
22406 News |
|
| «12...390391392393394395396397398399400401402» |
- Trial primary completion date: Sarcopenia and Cirrhosis (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=20, Recruiting, Sponsor: Rigshospitalet, Denmark
Trial primary completion date: Jan 2015 --> Dec 2015
- New trial: CPC2: Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia (clinicaltrials.gov) - Oct 22, 2015
P0, N=75, Not yet recruiting, Sponsor: Seoul National University Hospital
- || New P3 trial: SPRINTT: Multicomponent Intervention for Physical Frailty and Sarcopenia (clinicaltrials.gov) - Oct 22, 2015
P3, N=1500, Not yet recruiting, Sponsor: Catholic University of the Sacred Heart
- Trial completion, Enrollment change: Feasibility of a Resistance Exercise and Dietary Protein Intervention in Elderly People in Practice (ProMuscle 65PK) (clinicaltrials.gov) - Oct 8, 2015
P=N/A, N=23, Completed, Sponsor: Wageningen University
Trial primary completion date: Jan 2015 --> Dec 2015 Recruiting --> Completed | N=30 --> 23
- New trial: MUSFAT: Muscle Loss and Fatigue as a Consequence of Radiotherapy (clinicaltrials.gov) - Oct 5, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: Essentia Health
- Enrollment change, Trial initiation date, Trial withdrawal: The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men (clinicaltrials.gov) - Oct 3, 2015
P4, N=0, Withdrawn, Sponsor: The University of Texas Medical Branch, Galveston
Recruiting --> Completed | N=30 --> 23 N=45 --> 0 | Initiation date: Mar 2015 --> Jan 2016 | Not yet recruiting --> Withdrawn
- Enrollment open, Trial primary completion date: SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia (clinicaltrials.gov) - Sep 30, 2015
P=N/A, N=366, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
N=45 --> 0 | Initiation date: Mar 2015 --> Jan 2016 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2015 --> Aug 2016
- Enrollment closed: PREFISSARC: Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture (clinicaltrials.gov) - Sep 29, 2015
P=N/A, N=200, Active, not recruiting, Sponsor: Hospital Viamed Valvanera, Spain
Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2015 --> Aug 2016 Recruiting --> Active, not recruiting
- Enrollment closed: HIPERPROT: Hyperprotein Nutritional Intervention in Elderly Patients With Hip Fracture and Sarcopenia (clinicaltrials.gov) - Sep 29, 2015
P=N/A, N=110, Active, not recruiting, Sponsor: Hospital Viamed Valvanera, Spain
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=300, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Phase classification: Nutrition and Exercise for Sarcopenia (clinicaltrials.gov) - Sep 9, 2015
P1, N=108, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Recruiting --> Active, not recruiting Phase classification: P=N/A --> P1
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Phase classification: Insulin and Sarcopenia in the Elderly (clinicaltrials.gov) - Sep 9, 2015
P1, N=88, Terminated, Sponsor: The University of Texas Medical Branch, Galveston
Phase classification: P=N/A --> P1 Phase classification: P=N/A --> P1
- New trial: Semi-Recumbent Vibration Therapy in Older Adults (clinicaltrials.gov) - Aug 26, 2015
P=N/A, N=32, Recruiting, Sponsor: University of Wisconsin, Madison
- |||| bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Enrollment open, Trial primary completion date: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (clinicaltrials.gov) - Aug 26, 2015
P2, N=240, Recruiting, Sponsor: Novartis Pharmaceuticals
Phase classification: P=N/A --> P1 Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Feb 2017
- New trial: F-POW: Functional Changes and Power Training in Older Women. (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=50, Recruiting, Sponsor: University of Toronto
- New trial: The Benefits of Hemp Protein Supplementation During Resistance Training (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=40, Recruiting, Sponsor: University of Saskatchewan
- New trial: BCHA: Nutrient Support to Body Composition and Healthy Ageing (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=300, Active, not recruiting, Sponsor: University of Limerick
- Trial completion, Trial primary completion date: Omega-3 Fatty Acids to Combat Sarcopenia (clinicaltrials.gov) - Aug 17, 2015
P=N/A, N=24, Completed, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Feb 2017 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jul 2015
- ||| Trial completion: Health and Nutrition Status of Chinese Elderly (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=2834, Completed, Sponsor: Abbott Nutrition
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Jul 2015 Recruiting --> Completed
- New trial: ExPrEs: Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes (clinicaltrials.gov) - Jul 28, 2015
P=N/A, N=60, Recruiting, Sponsor: University of Maryland
- Enrollment open: Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=20, Recruiting, Sponsor: McMaster University
Recruiting --> Completed Not yet recruiting --> Recruiting
- New trial: SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=366, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
- sirolimus / Generic mfg.
Trial completion: Nutritional and Contractile Regulation of Muscle Growth (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=144, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment change: Resistance Exercise for the Prevention of Age-related Sarcopenia (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Recruiting --> Completed N=30 --> 0
- ||| Enrollment open, Trial initiation date: Improving Muscle Assessment in Older Adults - The "Can We Build a Better Mouse Trap?" Study (clinicaltrials.gov) - Jun 17, 2015
P=N/A, N=112, Recruiting, Sponsor: University of Wisconsin, Madison
N=30 --> 0 Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Feb 2015
- || Trial primary completion date: Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Feb 2015 Trial primary completion date: Apr 2015 --> Apr 2016
- ||||| bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
New P2 trial: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (clinicaltrials.gov) - Jun 11, 2015
P2, N=240, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
- ||| New trial: EXVITD: Vitamin D and Resistance Exercise Training; Effects on Musculoskeletal Health in Frail Older Men and Women (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=114, Not yet recruiting, Sponsor: University of Birmingham
- Enrollment open: Impact of Vitamin D on 25-hydroxyvitamin D Levels and Physical Function (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=100, Recruiting, Sponsor: Tufts University
Trial primary completion date: Apr 2015 --> Apr 2016 Not yet recruiting --> Recruiting
- Trial completion, Enrollment change, Trial primary completion date: ESPRO2: NMES During the Day and Prior to Sleep (clinicaltrials.gov) - May 21, 2015
P=N/A, N=16, Completed, Sponsor: Maastricht University Medical Center
Not yet recruiting --> Recruiting Recruiting --> Completed | N=12 --> 16 | Trial primary completion date: Sep 2015 --> May 2015
- Enrollment closed, Trial primary completion date: MUSCLED: Muscle Ultrasound for Sarcopenia Leading to Early Detection (clinicaltrials.gov) - May 19, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: George Washington University
Recruiting --> Completed | N=12 --> 16 | Trial primary completion date: Sep 2015 --> May 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jun 2015
- Trial completion: Study of the Long-term Effects of Exercise on Heath Indicators in Older People (clinicaltrials.gov) - May 16, 2015
P=N/A, N=90, Completed, Sponsor: University of Tr
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jun 2015 Active, not recruiting --> Completed
- New trial: Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults (clinicaltrials.gov) - May 13, 2015
P=N/A, N=127, Completed, Sponsor: University of Alabama at Birmingham
- New trial: Feasibility of a Resistance Exercise and Dietary Protein Intervention in Elderly People in Practice (ProMuscle 65PK) (clinicaltrials.gov) - May 5, 2015
P=N/A, N=30, Recruiting, Sponsor: Wageningen University
- Trial completion, Trial primary completion date: PRO-ADAPT: Manipulation of Dietary Protein and the Anabolic Response (clinicaltrials.gov) - May 5, 2015
P=N/A, N=28, Completed, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Mar 2015
- ||| Trial completion: Olive Oil Polyphenols, Vitamin D, Docosahexaenoic Acid (DHA) and Locomotor Function (PolivD3) (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=149, Completed, Sponsor: Lesieur
Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Mar 2015 Active, not recruiting --> Completed
- || bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Trial primary completion date: Dose Range Finding Study of Bimagrumab in Sarcopenia (clinicaltrials.gov) - Apr 28, 2015
P2, N=280, Recruiting, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> Dec 2016
- Trial primary completion date: MM-DC: Estimation of Muscle Mass in Older Adults Using Deuterated Creatine (clinicaltrials.gov) - Apr 27, 2015
P=N/A, N=62, Recruiting, Sponsor: University Hospital, Toulouse
Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: Mar 2015 --> Mar 2016
- New trial: Glucose Metabolism, Muscle Mass/Function and Inflammation in the Elderly (clinicaltrials.gov) - Apr 25, 2015
P=N/A, N=76, Not yet recruiting, Sponsor: Catholic University of the Sacred Heart
- Enrollment change, Trial withdrawal, Trial primary completion date: Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=0, Withdrawn, Sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Trial primary completion date: Mar 2015 --> Mar 2016 N=26 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2014 --> Apr 2013
- ||||| New P1/2 trial: Citrulline Supplementation Combined With Exercise: Effect on Muscle Function in Elderly People (CITEX Study) (clinicaltrials.gov) - Apr 22, 2015
P1/2, N=64, Not yet recruiting, Sponsor: Universite du Quebec a Montreal
- Trial primary completion date: PREFISSARC: Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=200, Recruiting, Sponsor: Hospital Viamed Valvanera, Spain
N=26 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2014 --> Apr 2013 Trial primary completion date: Sep 2013 --> Dec 2015
- Trial primary completion date: Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia (clinicaltrials.gov) - Apr 18, 2015
P=N/A, N=10, Recruiting, Sponsor: University of Florida
Trial primary completion date: Sep 2013 --> Dec 2015 Trial primary completion date: Mar 2015 --> Mar 2016
- Trial primary completion date, PARP Biomarker: Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle (clinicaltrials.gov) - Apr 18, 2015
P=N/A, N=63, Active, not recruiting, Sponsor: University of Florida
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Mar 2015 --> Sep 2015
- ||||| New P1/2 trial: Citrulline Supplementation Combined With Exercise: Effect on Muscle Function in Elderly People (CITEX Study) (clinicaltrials.gov) - Apr 15, 2015
P1/2, N=60, Not yet recruiting, Sponsor: Universite du Quebec a Montreal
- Trial primary completion date: Effects of Fun Physical Activity on the Interest to Daily Physical Activity and Sarcopenia of Elderly People (clinicaltrials.gov) - Apr 14, 2015
P1/2, N=63, Recruiting, Sponsor: Mashhad University of Medical Sciences
Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Oct 2014 --> Apr 2015
- Trial primary completion date: MaSS - Maastricht Sarcopenia Study (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=252, Active, not recruiting, Sponsor: Maastricht University Medical Center
Trial primary completion date: Oct 2014 --> Apr 2015 Trial primary completion date: Oct 2014 --> Mar 2014
- Enrollment open: Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=135, Recruiting, Sponsor: Chinese University of Hong Kong
Trial primary completion date: Oct 2014 --> Mar 2014 Not yet recruiting --> Recruiting
- || Enrollment closed, Trial primary completion date: Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults (clinicaltrials.gov) - Apr 7, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Apr 2015
- |||| trevogrumab (REGN1033) / Regeneron, Sanofi
Trial completion: Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia (clinicaltrials.gov) - Apr 3, 2015
P2, N=253, Completed, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Apr 2015 Active, not recruiting --> Completed